SA
CL icon

Sicart Associates’s Colgate-Palmolive CL Stock Holding History

Sicart Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,200
Closed -$836K – 80
2019
Q1 		$836K Hold
12,200
– – 0.35% 51
2018
Q4 		$726K Hold
12,200
– – 0.35% 52
2018
Q3 		$817K Hold
12,200
– – 0.39% 51
2018
Q2 		$791K Hold
12,200
– – 0.41% 52
2018
Q1 		$874K Hold
12,200
– – 0.52% 46
2017
Q4 		$920K Buy
12,200
+6,000
+97% +$438K 0.49% 50
2017
Q3 		$452K Buy
6,200
+1,200
+24% +$86.5K 0.32% 57
2017
Q2 		$371K Hold
5,000
– – 0.27% 64
2017
Q1 		$366K Buy
+5,000
New +$350K 0.26% 70

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Sicart Associates's CL Position: Q2 2019 in Review

Sicart Associates sold out of Colgate-Palmolive (CL) in Q2 2019, closing a stake of 12,200 shares — an estimated $836K sold.

Sicart Associates first reported a position in CL in Q1 2017 and held it in 9 quarters. The position peaked at $920K in Q4 2017. 1,457 funds tracked by Wall St. Rank hold CL as of Q2 2019.

  • Sicart Associates reported no remaining Colgate-Palmolive position as of Q2 2019 after selling out during the quarter.
  • Sicart Associates sold 12,200 Colgate-Palmolive shares in Q2 2019, an estimated $836K.
  • Sicart Associates first reported a position in Colgate-Palmolive in Q1 2017 and held it in 9 quarters.
  • Sicart Associates's Colgate-Palmolive position peaked at $920K in Q4 2017.
  • 1,457 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2019.

Based on Sicart Associates's 13F filing for Q2 2019, filed 23 Jul 2019.